Vera Therapeutics, Inc. (VERA) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VERA Revenue Growth
VERA Revenue Analysis (2019–2025)
As of May 8, 2026, Vera Therapeutics, Inc. (VERA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, VERA's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including CLDX (-78.6% YoY), HALO (+37.6% YoY), and ARWR (+14.1% YoY). Compare VERA vs CLDX →
VERA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VERACurrent | $0 | - | - | - | |
 CLDX | $2M | -78.6% | -27.4% | -19160.0% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% |
VERA Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-468,000 | - | $-315,473,000 | - |
| 2024 | $0 | - | $0 | - | $-167,170,000 | - |
| 2023 | $0 | - | $0 | - | $-102,012,000 | - |
| 2022 | $0 | - | $846K | - | $-90,903,000 | - |
| 2021 | $0 | - | $0 | - | $-34,402,000 | - |
| 2020 | $0 | - | $-251,000 | - | $-48,060,000 | - |
| 2019 | $0 | - | $-509,000 | - | $-11,961,000 | - |
See VERA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VERA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VERA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVERA — Frequently Asked Questions
Quick answers to the most common questions about buying VERA stock.
Is VERA's revenue growth accelerating or slowing?
VERA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is VERA's long-term revenue growth rate?
Vera Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is VERA's revenue distributed by segment?
VERA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.